Lifecycle Planning

Lifecycle Planning

Effective planning throughout asset lifecycle can assure sustained franchise level revenue & profit optimization – MKTXS has the tools and experience to support your product post-launch 

Indication Sequencing

MKTXS will identify the optimal launch order for assets with multiple indications based on inherent value in each indication while considering current/future competition, dosing variance, and line-extension policies at national/regional level  

Product Franchise Revenue Impact

MKTXS has internal expertise to assess the price impact as a result of key market events including: 

  • Price increases 
  • Generic/biosimilar entry impact 
  • Cross border trades (CBT)
  • International reference pricing (IRP) 

 

MKTXS platforms used for Lifecycle Planning

MVAP

Market Access Value Assessment Platform

CARVE

Continued Access Reinforced by Value Evidence

PHARMA.AI

Pharmaceutical Analog Index